MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
52.17
+0.29 (0.56%)
Dec 20, 2024, 4:00 PM EST - Market closed
MLTX Market Cap
MLTX has a market cap or net worth of $3.29 billion as of December 20, 2024. Its market cap has decreased by -0.65% in one year.
Market Cap
3.29B
Enterprise Value
2.80B
1-Year Change
-0.65%
Ranking
Category
Stock Price
$52.17
Market Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $3.29B, an increase of 91,338.94%. That is a compound annual growth rate of 994.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 3.29B | -9.11% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CRISPR Therapeutics AG | 3.45B |
| Rhythm Pharmaceuticals | 3.41B |
| Verona Pharma | 3.37B |
| Oscar Health | 3.33B |
| NovoCure | 3.29B |
| Inari Medical | 3.19B |
| Envista Holdings | 3.10B |
| Denali Therapeutics | 3.09B |